Refine by
Environmental Research Articles & Analysis
128 news found
Hemostemix Inc. (TSX-V: HEM; OTCQB: HMTXF; FSE: 2VF0), an autologous (patient’s own) stem cell therapy company offering VesCell™ (ACP-01) to individuals suffering from peripheral arterial disease, chronic limb threatening ischemia, angina, ischemic cardiomyopathy, non ischemic dilated cardiomyopathy, congestive heart failure, and total body ischemia, under Florida’s SB 1768, ...
Hemostemix Inc. (TSX-V: HEM; OTCQB: HMTXF; FSE: 2VF0), the leading autologous (patient’s own) stem cell therapy company offering treatments for no-option patients in Florida suffering from Chronic Limb Threatening Ischemia, Peripheral Arterial Disease, Angina, Ischemic Cardiomyopathy, non Ischemic Dilated Cardiomyopathy, and Congestive Heart Failure, is pleased to announce additions to ...
Hemostemix Inc. (“Hemostemix” or the “Company”) (TSXV: HEM, OTCQB: HMTXF; FSE:2VF0), the leading autologous (patient’s own) stem cell therapy company treating no-option patients in Florida suffering in pain from Chronic Limb Threatening Ischemia, Peripheral Arterial Disease and Angina, is pleased to announce its webinar topic for Thursday, August 21, 2025. Croom ...
Hemostemix (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company“) is excited to highlight a groundbreaking research article published in Cells on June?29,?2025, by Dr. Fraser C. Henderson Sr. and Ms. Kelly?Tuchman, exploring how a combination of the patient’s own ACP-01 and NCP-01 (autologous blood-derived cell precursors) may support the long-term ...
CERC is delighted to be part of the new consortium running the Mayor of London's Breathe London network. The consortium will coordinate all 136 existing air quality sensor sites across the capital, introducing advanced methodologies for sensor calibration and data quality assurance, and engaging key community groups and organisations such as schools, NHS Trusts and Local Authorities to make ...
According to a recent survey by the American Pet Products Association, 82 million households in the United States own a pet. For many, their pet is a part of the family, but unfortunately, many homes with pets also suffer from indoor environmental quality issues associated with pet odors and allergens. Both furry pets and those with feathers can cause an allergic reaction in some people. Pet ...
A recent survey found that close to 50% of households in Puerto Rico have at least one pet. For many, their pet is a part of the family, but unfortunately, many homes with pets also suffer from indoor environmental quality (IEQ) issues associated with pet odors and allergens. Both furry pets and those with feathers can cause an allergic reaction in some people. Pet dander is a significant ...
This service can be a game-changer for researchers in ecology, medicine, environmental science, food safety, and more. Whether researchers are on the hunt for novel microbial species, investigating disease etiology, conducting environmental monitoring, or studying microbial communities in the context of human health, CD Genomics' ...
The event featured thousands of presentations on cutting-edge research, as well as numerous opportunities for networking and collaboration. ...
Throughout the United States, asthma caused 5.8 million physician office visits and 1.6 million emergency department visits as recently as 2021. Tragically, there were also 4,145 deaths due to asthma the year before. These figures point to the toll asthma has on individuals and families, as well as lost time in classrooms, decreased productivity in the workplace and the tremendous medical costs ...
Allergy and asthma rates in Puerto Rico are much higher than most other parts of the United States. There are a number of factors for why this is likely the case, including the region’s tropical climate which is conducive for the growth of mold and year-round pollen. Flowering plants, trees and grasses release pollen into the environment. The fine powdery substance can be carried by the ...
The annual ADMS User Group Meetings are a great opportunity to hear the latest ADMS model news and advice from CERC consultants and model developers and to hear talks by model users about their own applications of the software. Normally held as two one-day meetings, with one day for ADMS 5 users and one day for ADMS-Urban & ADMS-Roads users, this year due to the COVID-19 pandemic we are ...
Innovate UK launched Women in Innovation in 2016, after research revealed that just 1 in 7 applications for Innovate UK support came from women. ...
“It is imperative that we have a better understanding of how the risks are changing” Swiss scientists report in the journal Environmental Research Letters that even if the world keeps to an agreement to limit global warming to no more than 2°C, because the global population is rising, the average risk of displacement by river flooding is likely ...
It’s nothing short of miraculous that COVID-19 tests, N95 respirators and SARS-CoV2 vaccines were made available so quickly. But, sadly we are compelled to ask…are they real or counterfeit? Since December of 2019, herculean efforts have resulted in amazing strides in warp speed towards development, supply and distribution of disease-confirming analytical tools, disease-mitigating ...
The Breathe London Pilot network of static AQMesh air quality sensors has been extended into the COVID-19 recovery period. This will create a fully validated dataset covering the latest phases of the recovery. Furthermore, it will provide critical analysis, including source apportionment and emission index quantification, and data assimilation to determine emissions during the recovery phase ...
Stem Pharm has been awarded a $1.7 million SBIR grant from the National Institute of Environmental Health Sciences of the National Institutes of Health (NIH) to optimize its induced pluripotent stem cell (iPSC)-derived model of the central nervous system for drug discovery and toxicology applications. Stem Pharm’s model fills a commercial need to accurately reflect the complexity of cell ...
The treatment – created by researcher Liping Zhao – was given the Investigational New Drug status by the Food and Drug Administration and will start Phase 2a trial Feb. 8. ...
The paper published in Nature Scientific Reports was borne out of research conducted by Dr. Herron and his team in the Frankel Cardiovascular Regeneration Core Laboratory. ...
The British Occupational Hygiene Society, a scientific charity and the Chartered Society for Workplace Health Protection, is welcoming research published by Imperial College London’s DEMist project, which uses black carbon to track exposure of professional drivers to diesel exhaust. The study led by Dr Ian Mudway, Senior Lecturer at the MRC Centre for Environment and ...